Form 4: IN8BIO CFO Acquires Shares Amidst Reverse Stock Split

IN8BIO's Chief Financial Officer, Patrick McCall, acquired 7,247 shares of common stock at $1.38 per share, increasing his direct beneficial ownership to 9,482 shares, following a recent reverse stock split.

Summary

• Patrick McCall, Chief Financial Officer of IN8BIO, INC. (INAB), acquired 7,247 shares of common stock.
• The transaction occurred on December 22, 2025, at a price of $1.38 per share.
• Following this acquisition, Mr. McCall directly beneficially owns a total of 9,482 shares of IN8BIO common stock.
• The reported share numbers have been adjusted to reflect a 1-for-30 reverse stock split that became effective on June 3, 2025.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive (CFO) is generally perceived as a positive signal, indicating confidence in the company's future. The transaction price also suggests a belief in the stock's value.

Positives

• The Chief Financial Officer's acquisition of common stock signals management's confidence in the company's future prospects and valuation.
• The purchase at $1.38 per share indicates a specific price point at which an insider sees value.

Future Outlook

The filing does not contain any explicit forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the transaction itself.

Industry Context

Insider buying, such as this transaction by IN8BIO's CFO, is often viewed by investors as a positive indicator, suggesting that those with intimate knowledge of the company believe its stock is undervalued or poised for growth. This action aligns with a general trend where management's personal investment can bolster market confidence, particularly in the biotechnology sector where future potential is often a key driver of valuation.

Stakeholder Impact

• Shareholders may interpret the CFO's stock purchase as a positive sign of management's belief in the company's value and future prospects, potentially influencing investor sentiment.

Key Dates

Recommendation

While the insider purchase by the CFO is a positive signal, suggesting management confidence and potential undervaluation, a single Form 4 filing typically does not provide sufficient comprehensive information to issue a 'buy' or 'sell' recommendation. Investors should consider this transaction as one data point within a broader due diligence process, warranting a 'hold' stance while awaiting further financial and operational updates.

Keywords

IN8BIO, INAB, Insider Trading, Stock Acquisition, CFO, Form 4, Common Stock, Reverse Stock Split